Archives: “Archives”

Eli Sprecher, MD, PhD

https://www.coltonconsortium.org/directory/eli-sprecher-md-phd/

Professor, Dermatology, Gray Faculty of Medical and Health Sciences, Tel Aviv University CEO of Sourasky Medical Center (Ichilov), Tel Aviv Sourasky Medical Center, Tel Aviv University Dr. Eli Sprecher is […]

Mary Tomayko, MD, PhD

https://www.coltonconsortium.org/directory/mary-tomayko-md-phd/

Associate Professor, Department of Dermatology, Yale School of Medicine, Yale University Associate Professor, Department of Pathology, Yale School of Medicine, Yale University Director Yale Immunobullous Clinic, Department of Dermatology, Yale […]

Lev Pavlovsky, MD

https://www.coltonconsortium.org/directory/lev-pavlovsky-md/

Lecturer, Tel Aviv University; Rabin Medical CenterDermatology Dr. Lev Pavlovsky is a Clinical Associate Professor of Dermatology at the Gray Faculty of Medical and Health Sciences, Tel Aviv University, and […]

Christoph Ellebrecht, MD

https://www.coltonconsortium.org/directory/christoph-ellebrecht-md/

Assistant Professor, Department of Dermatology, Perelman School of Medicine, University of Pennsylvania Dr. Christoph Ellebrecht is an Assistant Professor of Dermatology at the Perelman School of Medicine, University of Pennsylvania, […]

The Epidermis as a Novel Therapeutic Target in Pemphigus Vulgaris

https://www.coltonconsortium.org/projects/the-epidermis-as-a-novel-therapeutic-target-in-pemphigus-vulgaris/

By profiling genetic and molecular drivers of pemphigus vulgaris across patient skin and blood, this project uncovers genotype-driven inflammatory loops and actionable targets for personalized therapy.

Center of Excellence for Cell Therapy in Autoimmunity (CECTA)

https://www.coltonconsortium.org/projects/center-of-excellence-for-cell-therapy-in-autoimmunity-cecta/

Advancing engineered CAR and CAAR T cell therapies across multiple autoimmune diseases through clinical trials, preclinical development, and industry partnerships.

Penn Medicine’s Colton Center Is Driving the Next Immunotherapy Revolution — This Time for Autoimmune Disease

https://www.coltonconsortium.org/news/penn-medicines-colton-center-is-driving-the-next-immunotherapy-revolution-this-time-for-autoimmune-disease/

Penn Medicine's Colton Center is leading a new wave of precision immunotherapy for autoimmune disease — from CAAR T cell therapy for pemphigus to immune profiling tools that could one day cure these conditions.

Yale Researchers Use Skin as a Window Into Autoimmune Disease — and a Path to Better Treatments

https://www.coltonconsortium.org/news/yale-researchers-use-skin-as-a-window-into-autoimmune-disease-and-a-path-to-better-treatments/

Yale Medicine Magazine profiles Colton-funded researchers using skin as a diagnostic and therapeutic entry point into autoimmune disease — from scleroderma antibody therapy to cancer-triggered bullous pemphigoid.